ID
37828
Description
Study ID: 104864/627 Clinical Study ID: 104864/627 Study Title: An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00061308 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan, Gemcitabine Study Indication: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
Keywords
Versions (2)
- 8/26/19 8/26/19 -
- 8/28/19 8/28/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 26, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Intravenous Topotecan and Gemcitabine as Second-line Treatment in Patients With Ovarian Cancer NCT00061308
Course 1 (Day 1 ) - Vital Signs; Administration of Study Medications
Description
Day 1 Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
Sitting after 5 mins.
Data type
integer
Measurement units
- mm[Hg]
Alias
- UMLS CUI [1]
- C0871470
Description
Sitting after 5 mins.
Data type
integer
Measurement units
- mm[Hg]
Alias
- UMLS CUI [1]
- C0428883
Description
Sitting after 5 mins.
Data type
integer
Measurement units
- beats/min
Alias
- UMLS CUI [1]
- C0232117
Description
Temperature
Data type
float
Alias
- UMLS CUI [1]
- C0005903
Description
Temperature Unit
Data type
integer
Alias
- UMLS CUI [1,1]
- C0005903
- UMLS CUI [1,2]
- C1519795
Description
Light clothes and shoes off. Round to the nearest kg or Ib.
Data type
integer
Alias
- UMLS CUI [1]
- C0005910
Description
Wieght Unit
Data type
integer
Alias
- UMLS CUI [1,1]
- C0005910
- UMLS CUI [1,2]
- C1519795
Description
Body Surface Area
Data type
float
Measurement units
- m2
Alias
- UMLS CUI [1]
- C0005902
Description
Topotecan Administration
Alias
- UMLS CUI-1
- C3469597
- UMLS CUI-2
- C0146224
Description
Total mg to be given (Topotecan)
Data type
float
Measurement units
- mg
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C0439810
- UMLS CUI [2]
- C0146224
Description
Date Administered (Topotecan)
Data type
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [2]
- C0146224
Description
Start Time (Topotecan)
Data type
time
Alias
- UMLS CUI [1]
- C1301880
- UMLS CUI [2]
- C0146224
Description
Stop Time (Topotecan)
Data type
time
Alias
- UMLS CUI [1]
- C1522314
- UMLS CUI [2]
- C0146224
Description
Was complete dose given? (Topotecan)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [2]
- C0146224
Description
If complete dose Topotecan was not given, provide actual mg given:
Data type
float
Measurement units
- mg
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [2]
- C0146224
Description
Gemicitabine Administration
Alias
- UMLS CUI-1
- C3469597
Description
Total mg to be given (Gemicitabine)
Data type
float
Measurement units
- mg
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C0439810
Description
Date Administered (Gemicitabine)
Data type
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
Description
Start Time (Gemicitabine)
Data type
time
Alias
- UMLS CUI [1]
- C1301880
Description
Stop Time (Gemicitabine)
Data type
time
Alias
- UMLS CUI [1]
- C1522314
Description
Was complete dose given? (Gemicitabine)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205197
Description
If complete dose Gemcitabine was not given, provide actual mg given:
Data type
float
Measurement units
- mg
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205197
Similar models
Course 1 (Day 1 ) - Vital Signs; Administration of Study Medications
C0600091 (UMLS CUI [1,2])
C0146224 (UMLS CUI-2)
C0439810 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0146224 (UMLS CUI [2])
C0146224 (UMLS CUI [2])
C0205197 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0205197 (UMLS CUI [1,2])
C0146224 (UMLS CUI [2])
C0439810 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,2])